Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

687 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial.
Earl HM, Vallier AL, Hiller L, Fenwick N, Young J, Iddawela M, Abraham J, Hughes-Davies L, Gounaris I, McAdam K, Houston S, Hickish T, Skene A, Chan S, Dean S, Ritchie D, Laing R, Harries M, Gallagher C, Wishart G, Dunn J, Provenzano E, Caldas C; Neo-tAnGo Investigators. Earl HM, et al. Among authors: caldas c. Lancet Oncol. 2014 Feb;15(2):201-12. doi: 10.1016/S1470-2045(13)70554-0. Epub 2013 Dec 19. Lancet Oncol. 2014. PMID: 24360787 Free article. Clinical Trial.
Pharmacogenetics of cancer chemotherapy.
Abraham J, Earl HM, Pharoah PD, Caldas C. Abraham J, et al. Among authors: caldas c. Biochim Biophys Acta. 2006 Dec;1766(2):168-83. doi: 10.1016/j.bbcan.2006.10.003. Epub 2006 Oct 25. Biochim Biophys Acta. 2006. PMID: 17141416 Review.
One-stop diagnostic breast clinics: how often are breast cancers missed?
Britton P, Duffy SW, Sinnatamby R, Wallis MG, Barter S, Gaskarth M, O'Neill A, Caldas C, Brenton JD, Forouhi P, Wishart GC. Britton P, et al. Among authors: caldas c. Br J Cancer. 2009 Jun 16;100(12):1873-8. doi: 10.1038/sj.bjc.6605082. Epub 2009 May 19. Br J Cancer. 2009. PMID: 19455145 Free PMC article.
Tamoxifen: the drug that came in from the cold.
Hughes-Davies L, Caldas C, Wishart GC. Hughes-Davies L, et al. Among authors: caldas c. Br J Cancer. 2009 Sep 15;101(6):875-8. doi: 10.1038/sj.bjc.6605231. Epub 2009 Aug 11. Br J Cancer. 2009. PMID: 19672259 Free PMC article. Review.
Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer.
Frye M, Dragoni I, Chin SF, Spiteri I, Kurowski A, Provenzano E, Green A, Ellis IO, Grimmer D, Teschendorff A, Zouboulis CC, Caldas C, Watt FM. Frye M, et al. Among authors: caldas c. Cancer Lett. 2010 Mar 1;289(1):71-80. doi: 10.1016/j.canlet.2009.08.004. Epub 2009 Sep 8. Cancer Lett. 2010. PMID: 19740597
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601).
Bartlett JM, Munro AF, Dunn JA, McConkey C, Jordan S, Twelves CJ, Cameron DA, Thomas J, Campbell FM, Rea DW, Provenzano E, Caldas C, Pharoah P, Hiller L, Earl H, Poole CJ. Bartlett JM, et al. Among authors: caldas c. Lancet Oncol. 2010 Mar;11(3):266-74. doi: 10.1016/S1470-2045(10)70006-1. Epub 2010 Jan 13. Lancet Oncol. 2010. PMID: 20079691 Free article.
687 results